Respiratory Muscle Strength as a Predictive Biomarker for Survival in Amyotrophic Lateral Sclerosis.
Michael I Polkey, Rebecca A Lyall, Ke Yang...
https://pubmed.ncbi.nlm.nih.gov/27494149/Actively Recruiting
Led by Thomas Jefferson University · Updated on 2026-09-28
70
Participants Needed
1
Research Sites
N/A
Total Duration
This research aims to find new ways to detect early changes linked to amyotrophic lateral sclerosis ALS, also called Lou Gehrigs disease. The study will investigate if changes in automatic breathing, brainstem and spinal cord imaging, and blood markers can identify early signs of ALS before major physical symptoms develop. It includes people with ALS, those with genetic risk but no symptoms, and healthy adults for comparison. Participants are divided into three groups those with symptomatic ALS, those carrying a genetic risk for ALS without symptoms, and healthy controls without neurological issues. Each group will undergo breathing and muscle function tests, magnetic resonance imaging MRI scans of the brainstem and spinal cord, and blood tests to examine biomarkers related to ALS. During a single study visit, participants will complete respiratory function tests, MRI scans, and blood sampling. The research team will measure the accuracy of a breathing impairment risk score for detecting ALS-related respiratory problems and assess MRI and blood biomarker levels. This observational study involves no treatment and aims to improve early diagnosis methods for ALS.
CONDITIONS
Developing New Ways to Detect Respiratory Impairment Early in ALS
J
Jayakrishnan Nair, PhD, PT
D
Dana Johnson, DPT
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Thomas Jefferson University
Lead Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Single study visit
Participants complete breathing and muscle tests, an MRI scan of the brainstem and spinal cord, and blood sampling to assess early ALS signs.
1 visit (in-person)
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Have more questions? Get in touch with our team for quick support
Michael I Polkey, Rebecca A Lyall, Ke Yang...
https://pubmed.ncbi.nlm.nih.gov/27494149/Benjamin De Leener, Simon Lévy, Sara M Dupont...
https://pubmed.ncbi.nlm.nih.gov/27720818/Jane E Butler
https://pubmed.ncbi.nlm.nih.gov/17660051/Lorena R Lizarraga-Valderrama, Graham K Sheridan
https://pubmed.ncbi.nlm.nih.gov/33728650/Barbara J Morgan, Russell Adrian, Melissa L Bates...
https://pubmed.ncbi.nlm.nih.gov/25080926/Arie R Gafson, Nicolas R Barthélemy, Pascale Bomont...
https://pubmed.ncbi.nlm.nih.gov/32408345/Nicole L Nichols, J Van Dyke, L Nashold...
https://pubmed.ncbi.nlm.nih.gov/23692930/S Shahrampour, B De Leener, M Alizadeh...
https://pubmed.ncbi.nlm.nih.gov/34326104/Adrienn G Varga, Sebastian N Maletz, Jordan T Bateman...
https://pubmed.ncbi.nlm.nih.gov/32396650/Lorenzo Gaetani, Kaj Blennow, Paolo Calabresi...
https://pubmed.ncbi.nlm.nih.gov/30967444/Thomas Jefferson University
Lead Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Collaborating Sponsor